Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

BASF Ends Plant Biotech Development For Europe

by Melody M. Bomgardner
January 23, 2012 | A version of this story appeared in Volume 90, Issue 4

BASF has decided to throw in the towel on efforts to develop and commercialize genetically modified crops for Europe. The company says it will move the headquarters of its plant science subsidiary from Limburgerhof, Germany, to Raleigh, N.C., in order to focus on markets in North and South America. BASF attributes the move to a lack of acceptance of biotechnology by European consumers, farmers, and politicians. In 2010, the company received regulatory approval from the European Commission to sell its Amflora genetically modified potato for cultivation in Europe, but it took 13 years to complete the approval process. BASF will halt commercialization of Amflora and two other potato varieties, as well as a wheat variety resistant to fungal disease. Instead, it will focus on higher yield and stress-resistant varieties of corn, soy, cotton, canola, and wheat for other markets. BASF will continue to conduct research at facilities in Ghent, Belgium, and in Berlin, but it will close sites in Gatersleben, Germany, and Svalöv, Sweden. Overall, BASF is cutting 140 positions in Europe.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.